Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast plus montelukast versus montelukast alone in severe uncontrolled asthma
2012-002064-27Phase 2Completed
- Sponsor
- Takeda
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of roflumilast and montelukast in asthma (2 arms), sponsored by Takeda. Primary endpoint: Change in trough pre-bronchodilator FEV1. Started Jun 2012; status: completed.
02
Drugs
roflumilastmontelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2012-002064-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002064-27.